Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.30B | 1.73B | 1.37B | 823.88M | 249.81M | Gross Profit |
1.02B | 860.97M | 475.04M | -673.11M | 9.08M | EBIT |
606.76M | 317.82M | -2.48M | -927.27M | -58.73M | EBITDA |
866.04M | 632.65M | 269.67M | -1.73B | -58.05M | Net Income Common Stockholders |
109.58M | 54.34M | -9.29M | -376.17M | -77.83M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
152.09M | 104.16M | 68.08M | 42.57M | 11.63M | Total Assets |
10.99B | 8.82B | 8.89B | 8.27B | 121.60M | Total Debt |
390.35M | 2.00B | 1.86B | 1.26B | 356.39M | Net Debt |
238.26M | 1.90B | 1.80B | 1.22B | 344.76M | Total Liabilities |
5.19B | 3.54B | 3.34B | 2.42B | 622.76M | Stockholders Equity |
2.13B | 1.53B | 1.60B | 1.66B | -507.69M |
Cash Flow | Free Cash Flow | |||
935.37M | 881.24M | 662.91M | 276.40M | 4.58M | Operating Cash Flow |
999.55M | 949.14M | 728.45M | 281.66M | 5.23M | Investing Cash Flow |
-638.14M | -118.03M | -485.22M | -1.60B | -652.00K | Financing Cash Flow |
-313.48M | -795.03M | -217.72M | 1.35B | -295.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $141.73B | 22.21 | 14.67% | 2.23% | 11.48% | 4.77% | |
71 Outperform | $26.23B | 86.70 | 5.99% | 3.88% | 32.56% | 72.39% | |
70 Outperform | $14.13B | 14.12 | 18.90% | 3.62% | 62.87% | ― | |
70 Outperform | $49.73B | 73.52 | 15.93% | 2.56% | 6.12% | -15.84% | |
67 Neutral | $154.99B | 35.12 | 34.07% | 3.00% | 24.92% | 16.65% | |
63 Neutral | $12.46B | 9.56 | 8.14% | 17044.64% | 12.63% | -4.25% | |
63 Neutral | $16.47B | ― | 0.05% | 3.75% | 46.69% | -98.56% |
On March 26, 2025, Blue Owl Capital Inc. appointed Jennifer Brouse to its Board of Directors, filling the vacancy left by Sean Ward’s resignation. Brouse, who is already a Managing Director and Chief Operating Officer at Blue Owl, will not receive additional compensation for her new role. This appointment was made under the terms of the Investor Rights Agreement, highlighting the company’s ongoing strategic alignment with its equity holders.